FDA
-
-
-
-
-
-
-
PureTech Health Plc (PRTC) Issues Year End Update and Outlook for 2024
-
-
-
-
-
-
-
Karuna Therapeutics Inc. (KRTX) Reports Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
-
-
-
-
-
-
-
Karuna Therapeutics Inc. (KRTX) Submits NDA for KarXT for the Treatment of Schizophrenia
-
-
-
-
-
-
-
Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
-
-
-
-
-
-
-
PureTech Health plc – Half-Year Report
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Karuna Therapeutics Inc. (KRTX)
-
-
-
-
-
-
-
Karuna Therapeutics Inc. (KRTX) Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
-
322,248 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

